The ISPE Singapore affiliate celebrated its 25th edition on August 27-29, 2025, with its flagship annual Conference & Exhibition, uniting a diverse assembly of industry leaders at Marina Bay Sand Expo, Singapore.
The official opening of the ISPE Singapore event was led by Shanshan Liu, International Board Director of ISPE, Conference Chair of ISPE Singapore, and Technical Director at No deviation, Singapore. The forum kick-started with welcoming remarks by Peiqing Zhang, President of ISPE Singapore and Scientific Director for Asia at Cytiva.
The event set the stage for a comprehensive exploration of potential devices and innovations, demonstrating the industry's stewardship and competence in driving innovative pharmaceutical development and digital transformation.
Several industry experts from a wide range of industries presented a wide range of topics over the two-day conference. In addition to participating in two open-track programs, participants had the opportunity to attend 15-minute power hour talks and to demo at exhibitor booths. Several lunch-and-learn workshops were also held.
Some of the spotlights of the event were Women in Pharma roundtable, a networking event for emerging business leaders, and a reception for Pharmanite.
A pre-conference site tour and workshops on pharmaceutical water systems, as well as exclusive ISPE training, were also offered. An ISPE-exclusive training course on Pharmaceutical Water Systems (T35) was offered before the conference, along with tours and workshops.
More than 2,600 attendees from 32 countries convened to delve into advancements in the biopharma industry through 74 sessions led by 109 speakers. Participation surged by 30% compared to 2024, with 50% of Southeast Asia attendees hailing from Malaysia and two-thirds of North Asia participants coming from China.
A diverse range of exhibitors, workshop facilitators, and contributors also participated in the event, reflecting ISPE’s broad engagement across the pharmaceutical industry. Participants were drawn from a diverse range of industries, with 22% representing manufacturing sectors spanning pharma, biopharma, and CDMOs, 13% from EPCM companies, and a notable rise in digital and automation providers alongside equipment suppliers.
The conference highlighted groundbreaking initiatives and leadership in pharmaceutical manufacturing and safety. Stephanie Ledwidge, Associate Life Sciences South East Asia at Linesight, Singapore, introduced the Lite Science Capital benchmark initiative, focusing on its role in driving localized impact.
A 25th anniversary celebration and speakers' dinner were held on August 28, to commemorate the event.
